BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hammouda MM, Elmaaty AA, Nafie MS, Abdel-motaal M, Mohamed NS, Tantawy MA, Belal A, Alnajjar R, Eldehna WM, Al‐karmalawy AA. Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies. Bioorganic Chemistry 2022;127:105995. [DOI: 10.1016/j.bioorg.2022.105995] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 El-Behairy MF, Abd-Allah WH, Khalifa MM, Nafie MS, Saleh MA, Abdel-Maksoud MS, Al-Warhi T, Eldehna WM, Al-Karmalawy AA. Design and synthesis of novel rigid dibenzo[b,f]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. J Enzyme Inhib Med Chem 2023;38:2157825. [PMID: 36629421 DOI: 10.1080/14756366.2022.2157825] [Reference Citation Analysis]
2 Al-Warhi T, Al-Karmalawy AA, Elmaaty AA, Alshubramy MA, Abdel-Motaal M, Majrashi TA, Asem M, Nabil A, Eldehna WM, Sharaky M. Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors. J Enzyme Inhib Med Chem 2023;38:176-91. [PMID: 36317648 DOI: 10.1080/14756366.2022.2135512] [Reference Citation Analysis]
3 Alzokaky AA, Al-Karmalawy AA, Saleh MA, Abdo W, Farage AE, Belal A, Abourehab MAS, Antar SA. Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice. Life Sci 2023;316:121390. [PMID: 36649752 DOI: 10.1016/j.lfs.2023.121390] [Reference Citation Analysis]
4 El-hela AA, Bakr MSA, Hegazy MM, Dahab MA, Elmaaty AA, Ibrahim AE, El Deeb S, Abbass HS. Phytochemical Characterization of Pterocephalus frutescens with In-Silico Evaluation as Chemotherapeutic Medicine and Oral Pharmacokinetics Prediction Study. Sci Pharm 2023;91:7. [DOI: 10.3390/scipharm91010007] [Reference Citation Analysis]
5 Al-Karmalawy AA, Nafie MS, Shaldam MA, Elmaaty AA, Antar SA, El-Hamaky AA, Saleh MA, Elkamhawy A, Tawfik HO. Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. J Med Chem 2023;66:777-92. [PMID: 36525642 DOI: 10.1021/acs.jmedchem.2c01668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Dash R, Biswal J, Yadav M, Sharma T, Mohapatra S, Prusty SK. Novel atorvastatin-curcumin conjugate nanogel, a selective COX2 inhibitor with enhanced biopharmaceutical profile: Design, synthesis, in silco, in vitro, and in vivo investigation. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104211] [Reference Citation Analysis]
7 Ahmed SA, Kamel MS, Aboelez MO, Ma X, Al-karmalawy AA, Mousa SAS, Shokr EK, Abdel-ghany H, Belal A, El Hamd MA, Al Shehri ZS, El Aleem Ali Ali El-remaily MA. Thieno[2,3-b]thiophene Derivatives as Potential EGFRWT and EGFRT790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies. ACS Omega 2022. [DOI: 10.1021/acsomega.2c06219] [Reference Citation Analysis]
8 Belal A, Abdel Gawad NM, Mehany ABM, Abourehab MAS, Elkady H, Al-Karmalawy AA, Ismael AS. Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. J Enzyme Inhib Med Chem 2022;37:1884-902. [PMID: 35801486 DOI: 10.1080/14756366.2022.2096019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
9 Saleh MA, Elmaaty AA, El Saeed HS, Saleh MM, Salah M, Ezz Eldin RR. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies. Bioorganic Chemistry 2022;129:106186. [DOI: 10.1016/j.bioorg.2022.106186] [Reference Citation Analysis]
10 Elmahdy MK, Zaki MO, Al-karmalawy AA, Abdo W, Alnasser SM, Antar SA. Glimepiride ameliorates renal toxicity induced by cadmium in mice: Modulation of Jun N terminal kinase (JNK)/nuclear factor kappa B (NF-κB) and phosphatidylinositol 3-kinases (PI3K)/protein kinase (AKT) pathways. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.121184] [Reference Citation Analysis]
11 Bhattacharya S, Sharma S, Prajapati BG. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.990841] [Reference Citation Analysis]
12 Shin SY, Jung E, Lee YH, Lim Y, Ahn S, Koh D, Eldehna W. Evaluation of 3,5-Diphenyl-2-Pyrazolines for Antimitotic Activity by Inhibition of Tubulin Polymerization. Journal of Chemistry 2022;2022:1-11. [DOI: 10.1155/2022/3567606] [Reference Citation Analysis]
13 Madbouly EA, Lashine EM, Al-karmalawy AA, Sebaiy MM, Pratsinis H, Kletsas D, Metwally K. Design and synthesis of novel quinazolinone–chalcone hybrids as potential apoptotic candidates targeting caspase-3 and PARP-1: in vitro, molecular docking, and SAR studies. New J Chem 2022. [DOI: 10.1039/d2nj04053k] [Reference Citation Analysis]